Sleep-disordered breathing in heart failure

European Journal of Heart Failure

Volumn 18, Issue 4, 2016, Pages 353-361

  Pearse, Simon G ^a   Cowie, Martin R ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Diagnosis; Heart failure; Sleep disordered breathing; Treatment

Indexed keywords

OXYGEN; REACTIVE OXYGEN METABOLITE;

BLOOD PRESSURE; CARDIOLOGIST; CARDIOVASCULAR DISEASE; CENTRAL SLEEP APNEA SYNDROME; DAYTIME SOMNOLENCE; DISEASE CLASSIFICATION; DISEASE MARKER; EVIDENCE BASED MEDICINE; HEALTH CARE UTILIZATION; HEART AFTERLOAD; HEART FAILURE; HEART PRELOAD; HOSPITALIZATION; HUMAN; HYPOXEMIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT COMPLIANCE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; SLEEP DISORDERED BREATHING; SYMPATHETIC TONE; SYMPTOM; SYSTOLIC HEART FAILURE; THORAX PRESSURE; ADRENERGIC SYSTEM; ATRIAL FIBRILLATION; COMPLICATION; HEALTH SERVICE; HEART; INFLAMMATION; MYOCARDIAL ISCHEMIA; PRESSURE; PROCEDURES; SLEEP APNEA, CENTRAL; SLEEP APNEA, OBSTRUCTIVE; SURVIVAL RATE; THORACIC CAVITY; UTILIZATION;

ATRIAL FIBRILLATION; CONTINUOUS POSITIVE AIRWAY PRESSURE; HEALTH SERVICES; HEART; HEART FAILURE; HEART FAILURE, SYSTOLIC; HOSPITALIZATION; HUMANS; INFLAMMATION; MYOCARDIAL ISCHEMIA; POSITIVE-PRESSURE RESPIRATION; PRESSURE; PROGNOSIS; QUALITY OF LIFE; REACTIVE OXYGEN SPECIES; SLEEP APNEA SYNDROMES; SLEEP APNEA, CENTRAL; SLEEP APNEA, OBSTRUCTIVE; SURVIVAL RATE; SYMPATHETIC NERVOUS SYSTEM; THORACIC CAVITY;

EID: 84958636447     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.492     Document Type: Review

References (68)

1. Mosterd A, Hoes AW,. Clinical epidemiology of heart failure. Heart 2007; 93: 1137-1146.
2. Stewart S, Ekman I, Ekman T, Odén A, Rosengren A,. Population impact of heart failure and the most common forms of cancer: a study of 1 162 309 hospital cases in Sweden (1988 to 2004). Circ Cardiovasc Qual Outcomes 2010; 3: 573-580.
3. Vazir A, Hastings PC, Dayer M, McIntyre HF, Henein MY, Poole-Wilson PA, McIntyre HF, Morrell MJ, Cowie MR, Simonds AK,. A high prevalence of sleep disordered breathing in men with mild symptomatic chronic heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 2007; 9: 243-250.
4. Bitter T, Faber L, Hering D, Langer C, Horstkotte D, Oldenburg O,. Sleep-disordered breathing in heart failure with normal left ventricular ejection fraction. Eur J Heart Fail 2009; 11: 602-608.
5. Punjabi NM,. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 2008; 5: 136-143.
6. Artz M, Woehrle H, Oldenburg O, Graml A, Suling A, Erdmann E, Teschler H, Wecheider K,. Prevalence and predictors of sleep-disordered breathing in patients with stable chronic heart failure: the SchlaHF reigstry. JACC Heart Fail 2016;4:116-125.
7. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P,. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012; 14: 803-869.
8. Yumino D, Redolfi S, Ruttanaumpawan P, Su MC, Smith S, Newton GE, Mak S, Bradley TD,. Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation 2010; 121: 1598-1605.
9. Javaheri S., A mechanism of central sleep apnea in patients with heart failure. N Eng J Med 1999; 341: 949-954.
10. Spaak J, Egri ZJ, Kubo T, Yu E, Ando S-I, Kaeko Y, Usui K, Bradley TD,. Muscle sympathetic nerve activity during wakefulness in heart failure patients with and without sleep apnea. Hypertension 2005; 46: 1327-1332.
11. Tkacova R, Niroumand M, Lorenzi-Filho G, Bradley TD,. Overnight shift from obstructive to central apneas in patients with heart failure: role of PCO2 and circulatory delay. Circulation 2001; 103: 238-243.
12. Hall MJ, Xie A, Rutherford R, Ando S, Floras JS, Bradley TD,. Cycle length of periodic breathing in patients with and without heart failure. Am J Respir Crit Care Med 1996; 154: 376-381.
13. Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK, Marcus CL, Mehra R, Parthasarathy S, Quan SF, Redline S, Strohl KP, Ward SLD TM,. Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. J Clin Sleep Med 2012; 8: 597-619.
14. Dimsdale JE, Coy T, Ziegler MG, Ancoli-Israel S, Clausen J,. The effect of sleep apnea on plasma and urinary catecholamines. Sleep 1995; 18: 377-381.
15. Kato M, Roberts-Thomson P, Phillips BG, Haynes WG, Winnicki M, Accurso V, Somers VK,. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000; 102: 2607-2610.
16. Martos R, Baugh J, Ledwidge M, O'Loughlin C, Conlon C, Patle A, Donnelly SC, McDonald K,. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 2007; 115: 888-895.
17. Yokoe T., Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003; 107: 1129-1134.
18. Bokinsky G, Miller M, Ault K, Husband P, Mitchell J,. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure-preliminary investigation. Chest 1995; 108: 625-630.
19. Kasai T, Floras JS, Bradley TD,. Sleep apnea and cardiovascular disease: a bidirectional relationship. Circulation 2012; 126: 1495-1510.
20. Schmalgemeier H, Bitter T, Fischbach T,. C-reactive protein is elevated in heart failure patients with central sleep apnea and Cheyne-Stokes respiration. Respiration 2013; 87: 113-120.
21. Bitter T, Westerheide N, Prinz C, Hossain MS, Vogt J, Langer C, Horstkotte D, Oldenburg O,. Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. Eur Heart J 2011; 32: 61-74.
22. Bitter T, Fox H, Dimitriadis Z, Niedermeyer J, Prib N, Prinz C, Horstkotte D, Oldenburg O,. Circadian variation of defibrillator shocks in patients with chronic heart failure: the impact of Cheyne-Stokes respiration and obstructive sleep apnea. Int J Cardiol 2014; 176: 1033-1035.
23. Gottlieb DJ, Yenokyan G, Newman AB, O'Connor GT, Punjabi NM, Quan SF, Redline S, Resnick HE, Tong EK, Diener-West M, Shahar E,. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the Sleep Heart Health Study. Circulation 2010; 122: 352-360.
24. Yumino D, Wang H, Floras JS, Newton GE, Mak S, Ruttanaumpawan P, Parker JD, Bradley TD,. Relationship between sleep apnoea and mortality in patients with ischaemic heart failure. Heart 2009; 95: 819-824.
25. McNicholas WT, Bonsignore MR,. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2006; 29: 156-178.
26. Javaheri S, Shukla R, Zeigler H, Wexler L,. Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol 2007; 49: 2028-2034.
27. Cowie MR, Woehrle H, Wegscheider K, Angermann C, D'Ortho M-P, Erdmann E, Levy P, Simonds AK, Somers VK, Zannad F, Teschler H,. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. N Engl J Med 2015; 373: 1095-1105.
28. Naughton MT,. Cheyne-Stokes respiration: friend or foe? Thorax 2012; 67: 357-360.
29. Brack T, Jubran A, Laghi F, Tobin MJ,. Fluctuations in end-expiratory lung volume during Cheyne-Stokes respiration. Am J Respir Crit Care Med 2005; 171: 1408-1413.
30. Mansfield D, Kaye DM, La Rocca HB, Solin P, Esler MD, Naughton MT,. Raised sympathetic nerve activity in heart failure and central sleep apnea is due to heart failure severity. Circulation 2003; 107: 1396-1400.
31. Wexels JC, Mjos OD,. Effects of carbon dioxide and pH on myocardial function in dogs with acute left ventricular failure. Crit Care Med 1987; 15: 1116-1120.
32. Chapman DG, Berend N, King GG, McParland BE, Salome CM,. Deep inspirations protect against airway closure in nonasthmatic subjects. J Appl Physiol 2009; 107: 564-569.
33. Levine M, Cleave JP, Dodds C,. Can periodic breathing have advantages for oxygenation? J Theor Biol 1995; 172: 355-368.
34. Randerath W, Khayat R, Arzt M, Javaheri S,. Sleep medicine-missing links. Sleep Med 2015; 16: 1495-1496.
35. Taranto Montemurro L, Floras JS, Millar PJ, Kasai T, Gabriel JM, Spaak J, Coelho FMS, Bradley TD,. Inverse relationship of subjective daytime sleepiness to sympathetic activity in patients with heart failure and obstructive sleep apnea. Chest 2012; 142: 1222-1228.
36. Quintana-Gallego E, Villa-Gil M, Carmona-Bernal C, Botebol-Benhamou G, Martínez-Martínez A, Sánchez-Armengol A, Polo-Padillo J, Capote F,. Home respiratory polygraphy for diagnosis of sleep-disordered breathing in heart failure. Eur Respir J 2004; 24: 443-448.
37. Pinna GD, Robbi E, Pizza F, Taurino AE, Pronzato C, La Rovere MT, Maestri R,. Can cardiorespiratory polygraphy replace portable polysomnography in the assessment of sleep-disordered breathing in heart failure patients? Sleep Breath 2014; 18: 475-482.
38. Vazir A, Hastings PC, Papaioannou I, Poole-Wilson PA, Cowie MR, Morrell MJ, Simonds AK,. Variation in severity and type of sleep-disordered breathing throughout 4 nights in patients with heart failure. Respir Med 2008; 102: 831-839.
39. Ward NR, Cowie MR, Rosen SD, Roldao V, De Villa M, McDonagh TA, Simonds A, Morrell MJ,. Utility of overnight pulse oximetry and heart rate variability analysis to screen for sleep-disordered breathing in chronic heart failure. Thorax 2012; 67: 1000-1005.
40. Hayano J, Watanabe E, Saito Y, Sasaki F, Fujimoto K, Nomiyama T, Kawai K, Kodama I, Sakakibara H,. Screening for obstructive sleep apnea by cyclic variation of heart rate. Circ Arrhythmia Electrophysiol 2011; 4: 64-72.
41. Shalaby A, Atwood C, Hansen C, Konermann M, Jamnadas P, Lee K, Willems R, Hartley J, Stahmann J, Kwok J, Ni Q, Neuzner J,. Feasibility of automated detection of advanced sleep disordered breathing utilizing an implantable pacemaker ventilation sensor. Pacing Clin Electrophysiol 2006; 29: 1036-1043.
42. Defaye P, de la Cruz I, Martí-Almor J, Villuendas R, Bru P, Sénéchal J, Tamisier R, Pepin J-L,. A pacemaker transthoracic impedance sensor with an advanced algorithm to identify severe sleep apnea: the DREAM European study. Heart Rhythm 2014; 11: 842-848.
43. National Institiute for Health and Care Excellence. Continuous Positive Airway Pressure for the Treatment of Obstructive Sleep Apnoea/Hypopnoea Syndrome. London: NICE; 2008.
44. Jing J, Huang T, Cui W, Shen H,. Effect on quality of life of continuous positive airway pressure in patients with obstructive sleep apnea syndrome: a meta-analysis. Lung 2008; 186: 131-144.
45. Mansfield DR, Gollogly NC, Kaye DM, Richardson M, Bergin P, Naughton MT,. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 2004; 169: 361-366.
46. Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T, Ando S-I, Bradley TD,. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003; 348: 1233-1241.
47. Colish J, Walker JR, Elmayergi N, Almutairi S, Alharbi F, Lytwyn M, Francis A, Bohonis S, Zeglinski M, Kirkpatrick IDC, Sharma S, Jassal DS,. Obstructive sleep apnea: effects of continuous positive airway pressure on cardiac remodeling as assessed by cardiac biomarkers, echocardiography, and cardiac MRI. Chest 2012; 141: 674-681.
48. Kasai T, Narui K, Dohi T, Yanagisawa N, Ishiwata S, Ohno M, Yamaguchi T, Momomura S-I,. Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. Chest 2008; 133: 690-696.
49. Damy T, Margarit L, Noroc A, Bodez D, Guendouz S, Boyer L, Drouot X, Lamine A, Paulino A, Rappeneau S, Stoica M-H, Dubois-Rande J-L, Adnot S, Hittinger L, d'Ortho MP,. Prognostic impact of sleep-disordered breathing and its treatment with nocturnal ventilation for chronic heart failure. Eur J Heart Fail 2012; 14: 1009-1019.
50. Javaheri S, Caref E Ben, Chen E, Tong KB, Abraham WT,. Sleep apnea testing and outcomes in a large cohort of Medicare beneficiaries with newly diagnosed heart failure. Am J Respir Crit Care Med 2011; 183: 539-546.
51. Mehta V, Vasu TS, Phillips B, Chung F,. Obstructive sleep apnea and oxygen therapy: a systemic review of the literature and meta-analysis. J Clin Sleep Med 2013; 9: 271-279.
52. Araghi MH, Chen Y-F, Jagielski A, Choudhury S, Banerjee D, Hussain S, Thomas GN, Taheri S,. Effectiveness of lifestyle interventions on obstructive sleep apnea (OSA): systematic review and meta-analysis. Sleep 2013; 36: 1553-1562.
53. Leite FGJ, Rodrigues RCS, Ribeiro RF, Eckeli AL, Regalo SCH, Sousa LG, Fernandes RMF, Valera FCP,. The use of a mandibular repositioning device for obstructive sleep apnea. Eur Arch Oto-Rhino-Laryngol 2014; 271: 1023-1039.
54. Javaheri S, Sands S, Edwards B,. Acetazolamide attenuates Hunter-Cheyne-Stokes breathing but augments the hypercapnic ventilatory response in patients with heart failure. Ann Am Thorac Soc 2014; 11: 80-86.
55. Sinha A-M, Skobel EC, Breithardt O-A, Norra C, Markus KU, Breuer C, Hanrath P,., Stellbrink C,. Cardiac resynchronization therapy improves central sleep apnea and Cheyne-Stokes respiration in patients with chronic heart failure. J Am Coll Cardiol 2004; 44: 68-71.
56. Lamba J, Simpson CS, Redfearn DP, Michael K, Fitzpatrick M, Baranchuk A,. Cardiac resynchronization therapy for the treatment of sleep apnoea: a meta-analysis. Europace 2011; 13: 1174-1179.
57. Staniforth A, Kinnear WJ, Starling R, Hetmanski DJ, Cowley A,. Effect of oxygen on sleep quality, cognitive function and sympathetic activity in patients with chronic heart failure and Cheyne-Stokes respiration. Eur Heart J 1998; 19: 922-928.
58. Nakao YM, Ueshima K, Yasuno S, Sasayama S,. Effects of nocturnal oxygen therapy in patients with chronic heart failure and central sleep apnea: CHF-HOT study. Heart Vessels 2016;31:165-172.
59. Sin DD, Logan AG, Fitzgerald FS, Liu PP, Bradley TD,. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000; 102: 61-66.
60. Bradley TD, Logan AG, Kimoff RJ, Sériès F, Morrison D, Ferguson K, Belenkie I, Pfeifer M, Fleetham J, Hanly P, Smilovitch M, Tomlinson G, Floras JS,. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005; 353: 2025-2033.
61. Arzt M, Floras JS, Logan AG, Kimoff RJ, Series F, Morrison D, Ferguson K, Belenkie I, Pfeifer M, Fleetham J, Hanly P, Smilovitch M, Ryan C, Tomlinson G, Bradley TD,. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial. Circulation 2007; 115: 3173-3180.
62. Teschler H, Döhring J, Wang YM, Berthon-Jones M,. Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med 2001; 164: 614-619.
63. Sharma BK, Bakker JP, McSharry DG, Desai AS, Javaheri S, Malhotra A,. Adaptive servoventilation for treatment of sleep-disordered breathing in heart failure: a systematic review and meta-analysis. Chest 2012; 142: 1211-1221.
64. Owada T, Yoshihisa A, Yamauchi H, Iwaya S, Suzuki S, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh SH, Takeishi Y,. Adaptive servoventilation improves cardiorenal function and prognosis in heart failure patients with chronic kidney disease and sleep-disordered breathing. J Card Fail 2013; 19: 225-232.
65. Koyama T, Watanabe H, Tamura Y, Oguma Y, Kosaka T, Ito H,. Adaptive servo-ventilation therapy improves cardiac sympathetic nerve activity in patients with heart failure. Eur J Heart Fail 2013; 15: 902-909.
66. Khayat R, Jarjoura D, Porter K, Sow A, Wannemacher J, Dohar R, Pleister A, Abraham WT,. Sleep disordered breathing and post-discharge mortality in patients with acute heart failure. Eur Heart J 2015; 36: 1463-1469.
67. Abraham WT, Jagielski D, Oldenburg O, Augostini R, Krueger S, Kolodziej A, Gutleben K-J, Khayat R, Merliss A, Harsch MR, Holcomb RG, Javaheri S, Ponikowski P,. Phrenic nerve stimulation for the treatment of central sleep apnea. JACC Heart Fail 2015; 3: 360-309.
68. Strollo PJ, Soose RJ, Maurer JT, de Vries N, Cornelius J, Froymovich O, Hanson RD, Padhya TA, Steward DL, Gillespie MB, Woodson BT, Van De Heyning PH, Goetting MG, Vanderveken OM, Feldman N, Knaak L, Strohl KP,. Upper-airway stimulation for obstructive sleep apnea. N Engl J Med 2014; 370:139-149.